Similar articles

• D-penicillamine-induced polymyositis in patients with rheumatoid arthritis.

  Takahashi K, Ogita T, Okudaira H, Yoshinoya S, Yoshizawa H, Miyamoto T. Takahashi K, et al. Arthritis Rheum. 1986 Apr;29(4):560-4. doi: 10.1002/art.1780290416. Arthritis Rheum. 1986. PMID: 3707633
• Penicillamine-induced myositis in rheumatoid arthritis.

  Morgan GJ Jr, McGuire JL, Ochoa J. Morgan GJ Jr, et al. Muscle Nerve. 1981 Mar-Apr;4(2):137-40. doi: 10.1002/mus.880040210. Muscle Nerve. 1981. PMID: 7207503
• Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis.

  Doyle DR, McCurley TL, Sergent JS. Doyle DR, et al. Ann Intern Med. 1983 Mar;98(3):327-30. doi: 10.7326/0003-4819-98-3-327. Ann Intern Med. 1983. PMID: 6830075
• [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].

  Dubost JJ, Soubrier M, Bouchet F, Kemeny JL, Lhopitaux R, Bussière JL, Sauvezie B. Dubost JJ, et al. Rev Neurol (Paris). 1992;148(3):207-11. Rev Neurol (Paris). 1992. PMID: 1604135 Review. French.
• [Association of polymyositis and rheumatoid arthritis. Apropos of a new case not related to drug ingestion].

  Jardin H, Cailleux N, Marie I, Lévesque H, Courtois H. Jardin H, et al. Rev Med Interne. 1996;17(4):321-4. doi: 10.1016/0248-8663(96)81436-6. Rev Med Interne. 1996. PMID: 8761796 Review. French.